SEC Filing Summary: Spherix Incorporated (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Spherix Incorporated on February 11, 2011. The registrant is incorporated in Delaware and maintains its principal executive offices in Bethesda, Maryland. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event rather than a financial statement.
Material Changes
There are no material financial changes reported in this document. The filing discloses a scheduled corporate presentation at the 13th Annual BIO CEO & Investor Conference.
Guidance, Outlook, and Management Commentary
- Event: Dr. Robert Lodder, President, and Dr. Claire Kruger, Chief Executive Officer, will present at the 13th Annual BIO CEO & Investor Conference.
- Date and Time: Tuesday, February 15, 2011, at 8:00 a.m.
- Location: Conrad Suite, Waldorf Astoria, New York, NY.
- Availability: The corporate presentation is available on the company website (www.spherix.com) and is attached as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the content of the attached presentation (Exhibit 99.1) for specific business updates or strategic shifts.
- Confirm the company's current stock price and trading volume following the announcement of the conference presentation.
- Review the company's website for the full text of the presentation to assess management's outlook.